## Company Overview

Abridge was founded in 2018 and operates within the Hospitals and Health Care industry. The company is headquartered in Pittsburgh, United States, and employs between 201-500 people. Abridge's mission is to enhance understanding in healthcare through its AI-powered platform, which improves clinical documentation efficiencies and transforms patient-clinician conversations into structured clinical notes in real-time. The company emphasizes deep EMR integrations and the responsible deployment of AI across health systems.

Website: [Abridge](https://www.abridge.com/)  
LinkedIn: [Abridge LinkedIn](https://www.linkedin.com/company/abridgehq)

## Business Model and GTM

The company states that its AI-powered platform is designed to improve clinical documentation efficiencies, allowing clinicians to focus more on patient care. Abridge's technology transforms medical conversations into structured notes, integrating deeply with electronic medical records (EMR). The company positions itself as a pioneer in generative AI for healthcare, setting industry standards for AI deployment in health systems.

## Funding & Investor Profile

Abridge has raised a total of $773 million across multiple funding rounds. The most recent funding was a $300 million Series E round in June 2025, led by Andreessen Horowitz, with participation from Khosla Ventures. The company is valued at $5.3 billion following this round. Other notable investors include Lightspeed Venture Partners, Redpoint Ventures, and IVP.

## Growth Momentum

Abridge's estimated annual revenue is $58 million, with a revenue per employee of approximately $178,000. The company has shown significant growth, with a total funding of $773 million and a valuation increase to $5.3 billion in 2025.

## Visibility & Market Sentiment

Abridge is recognized for its Best in KLAS AI-powered platform, which is purpose-built for medical conversations. The company is noted for its enterprise-grade technology and auditable AI, which helps providers trust and verify AI-generated outputs. Abridge's focus on responsible AI deployment in healthcare has positioned it as a leader in the industry.

## Risks and Challenges

Not disclosed.

## Outlook

The company is poised for continued growth, leveraging its strong funding base and strategic partnerships with leading investors. Abridge's focus on enhancing healthcare through AI and its commitment to responsible AI deployment position it well for future expansion and innovation in the healthcare sector.

## Disclosure Gaps

- Specific details on the company's business model and go-to-market strategy are not disclosed.
- Risks and challenges facing the company are not disclosed.
- Detailed financial performance metrics beyond revenue are not disclosed.